Fate Therapeutics Inc

Deschisă

SectorSănătate

2.04 -0.97

Rezumat

Modificarea prețului

24h

Curent

Minim

1.81

Maxim

2.14

Indicatori cheie

By Trading Economics

Venit

1.2M

-31M

Vânzări

-70K

1.3M

EPS

-0.26

Marjă de profit

-2,402.848

Angajați

161

EBITDA

14M

-28M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+154.37% upside

Dividende

By Acuity

Următoarele câștiguri

10 aug. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-2.9M

251M

Deschiderea anterioară

3.01

Închiderea anterioară

2.04

Sentimentul știrilor

By Acuity

50%

50%

141 / 342 Clasament în Healthcare

Fate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

25 iun. 2026, 23:51 UTC

News

Crude oil prices rise amid escalating Middle East tensions after a projectile strike near Oman. The United States Oil Fund LP is slightly higher after hours.

25 iun. 2026, 23:51 UTC

Social Media
Correlated Moves
News

Qualcomm is in talks to acquire Modular for $4 billion. Shares are trading lower after the company's optimistic revenue targets and Investor Day updates.

25 iun. 2026, 23:51 UTC

Social Media
News

Micron Technology Inc. shares fell in after-market trading despite a 350% year-over-year revenue increase, amid broader tech sector weakness.

25 iun. 2026, 23:42 UTC

News
Macro News
ETF Constituents

The Vanguard Information Technology ETF rose in after-market trading, boosted by Micron's strong earnings and revenue forecast, despite mixed broader market sentiment.

25 iun. 2026, 23:41 UTC

ETF Constituents
Social Media
News
Correlated Moves

SPDR S&P 500 ETF Trust trades higher after market close, supported by positive returns from top holdings like Microsoft and Apple amid mixed market sentiment.

25 iun. 2026, 23:41 UTC

News
ETF Constituents
Social Media

Invesco QQQ Trust Series I rises in after-market hours, supported by a gain in the Nasdaq 100. Microsoft, Apple, and Meta contributed positively to performance.

25 iun. 2026, 23:41 UTC

News
Social Media

Apple Inc. has raised prices for its MacBook and iPad models due to higher memory and storage costs. Shares are advancing in after-market trading.

25 iun. 2026, 23:41 UTC

Social Media
News

Microsoft shares are higher in after-market trading following Thursday's close. Analysts are cautious amid rising console storage costs and AI spending concerns.

25 iun. 2026, 23:26 UTC

News
ETF Constituents
Social Media

Vanguard Growth ETF shares advanced in after-market trading, supported by gains from Microsoft, Apple, and Meta, following four sessions of declines.

25 iun. 2026, 23:22 UTC

News

Tesla's energy division may drive growth amid EV market challenges. Shares traded roughly flat during after-market hours following Thursday's close.

25 iun. 2026, 23:06 UTC

ETF Constituents
News

The SPDR Dow Jones Industrial Average ETF Trust is higher in after-market trading, supported by positive economic data and contributions from Microsoft and Goldman Sachs.

25 iun. 2026, 20:07 UTC

News
Macro Event
Correlated Moves

The USD/SEK exchange rate is lower today, influenced by upward revisions in US GDP growth and personal spending figures.

25 iun. 2026, 20:07 UTC

News

Starbucks shares are lower despite reports of U.S. sales growth and upgraded earnings guidance. The stock pulled back from earlier session highs amid broader market dynamics.

25 iun. 2026, 20:07 UTC

Macro Event
News

Positive U.S. macroeconomic indicators lift USD/NOK, which is trading higher since Wednesday's close and remains near the upper end of its one-month range.

25 iun. 2026, 20:07 UTC

Macro Event
News

The USD/CZK exchange rate remains roughly flat, influenced by recent U.S. economic reports, including an upward revision of Q1 GDP growth to 2.1%.

25 iun. 2026, 20:07 UTC

Correlated Moves
News
Macro Event

The USD/PLN is trading lower today, influenced by recent U.S. economic data and a slight decline in the US Dollar Index.

25 iun. 2026, 20:07 UTC

News
Macro Event
Correlated Moves

The USD/HUF exchange rate is lower today, reflecting a slight decline since Wednesday. U.S. macroeconomic data contributed to recent volatility in the currency pair.

25 iun. 2026, 20:07 UTC

Correlated Moves
Macro Event
News

The USD/DKK exchange rate is declining, influenced by upward revisions in US GDP growth and muted responses to personal income and spending data.

25 iun. 2026, 20:07 UTC

News
Correlated Moves

The GBP/HKD exchange rate is rising, supported by an increase in GBP/USD amid ongoing inflation concerns and geopolitical tensions in the Strait of Hormuz.

25 iun. 2026, 20:07 UTC

News
Correlated Moves

Ethereum is lower today, influenced by Bitcoin's decline. It remains below its 20-day moving average and has finished lower for three consecutive sessions.

25 iun. 2026, 20:07 UTC

Correlated Moves
Macro Event
News

Bitcoin is lower today, impacted by the expiration of $10 billion in options and geopolitical tensions. Ethereum also declines, reflecting similar market conditions.

25 iun. 2026, 20:07 UTC

Macro Event
News
Correlated Moves

Bitcoin is lower today, driven by the expiration of $10 billion in options and geopolitical tensions following an attack in the Strait of Hormuz.

25 iun. 2026, 20:06 UTC

News

The Nikkei 225 Index is higher in after-market hours, supported by earlier gains and remaining above its 20-day moving average. No specific news was identified.

25 iun. 2026, 19:56 UTC

ETF Constituents
News
Correlated Moves

Vanguard Real Estate ETF is higher as Simon Property Group and Welltower contribute positively, despite uncertainty from the postponed housing affordability bill.

25 iun. 2026, 19:56 UTC

News
Macro Event
Social Media

Geopolitical tensions from an attack on a cargo ship have pressured U.S. Treasury yields, contributing to a decline in the iShares 20+ Year Treasury Bond ETF.

25 iun. 2026, 19:46 UTC

Correlated Moves
News

Ethereum is trading lower amid persistent inflation and geopolitical tensions affecting oil supply. The asset remains below its 20-day moving average.

25 iun. 2026, 19:26 UTC

News

Sirius XM Holdings Inc. is lower amid mixed US market performance and declines in major tech stocks, reflecting profit-taking and valuation concerns.

25 iun. 2026, 19:16 UTC

Correlated Moves
News

The U.S. core PCE price index rose in May, suggesting ongoing inflation. The Vanguard Mortgage-Backed Securities ETF is trading higher since Wednesday's close.

25 iun. 2026, 19:16 UTC

Macro Event
Correlated Moves
News

The Vanguard Total Bond Market ETF is higher today, supported by rising inflation data and an upward revision in Q1 GDP growth, reflecting stronger economic activity.

24 iun. 2026, 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

Comparație

Modificare preț

Fate Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

154.37% sus

Prognoză pe 12 luni

Medie 5.24 USD  154.37%

Maxim 8 USD

Minim 2.2 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruFate Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

9 ratings

5

Cumpărare

4

Păstrare

0

Vânzare

Sentiment

By Acuity

141 / 342 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Fate Therapeutics Inc

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
help-icon Live chat